Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
The Impact of Cardiac Rehabilitation on Muscle Strength – A Crucial Element of Functional Capacity
Session:
Sessão de Posters 48 - Exercício, Estilos de Vida e Obesidade
Speaker:
Marta Miguez Vilela
Congress:
CPC 2024
Topic:
J. Preventive Cardiology
Theme:
28. Risk Factors and Prevention
Subtheme:
28.14 Risk Factors and Prevention - Other
Session Type:
Cartazes
FP Number:
---
Authors:
Marta Miguez De Freitas Vilela; Ana Beatriz Garcia; Catarina Simões de Oliveira; Ana Margarida Martins; Daniela Roxo; Marta Ramalhinho; José Poupino; Margarida Alves; Nelson Cunha; Inês Aguiar-Ricardo; F.J. Pinto; Ana Abreu
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><u>Introduction</u></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">Cardiac rehabilitation (CR) is defined as a multidisciplinary program encompassing exercise training, modification of cardiovascular risk factors, and psychosocial assessment. Physician-prescribed exercise is a crucial and safe component that can significantly enhance the quality of life and functional capacity.</span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><u>Purpose</u></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">The purpose of this study is to assess whether improvements in muscular strength have an impact on functional capacity.</span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><u>Methods</u></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">A prospective analysis of patients enrolled in a cardiac rehabilitation phase two program was conducted. Standardized forms were utilized to collect patient data, including baseline characteristics, muscle strength evaluation (upper and lower limb strength and Time Up and Go test), the six-minute walking test (6MWT), and cardiopulmonary exercise test. Descriptive and inferential statistics were performed.</span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><u>Results</u></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">We enrolled 446 patients participating in the phase two CR program (81% male; mean age at the program's beginning was 61 years). The mean number of exercise sessions performed was 14. Among them, 85% had ischemic heart disease, 6% had valvular heart disease, and 3% had dilated cardiomyopathy. During the initial assessment, 73% of patients were in NYHA functional class II, 19% in NYHA I, and 8% in NYHA III. Forty-three percent of patients had a reduced left ventricular ejection fraction (LVEF <50%). Throughout the CR program, there was an improvement in lower limb (mean value increased from 15 Kg to 20 Kg, p=0.001), upper limb strength (mean value increased from 19 to 23 Kg, p=0.001), and in the time taken for the Up and Go test (a decrease in mean time from 14 s to 9 s, p=0.001). Patients demonstrating improvement in at least one of these parameters also showed, at the end of the programme, enhanced 6MWT mean time (from 454 to 569 meters), peak VO2 (from 15 to 17 mL/Kg/min), and the duration of cardiopulmonary stress testing (from 7:50 to 8:39) (p=0.001). In patients with reduced LVEF, there were a tendency toward enhanced 6MWT time in those who showed improvement in all the three upper and lower limb strength and in the Time Up and Go test compared with those who do not improve in all these tests (620 to 553 meters), which did not reach significance.</span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><u>Conclusion</u></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">Strength exercise is a vital component of CR programs and can significantly contribute to improvements in functional capacity. Therefore, its practice should be emphasized to enhance overall program effectiveness. Particularly in patients with reduced ejection fraction, a global strength improvement can have a positive impact on daily life functional capacity.</span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site